SMART Designs Tool to Investigate Bacteria Behind Hospital Infections Kumar Jeetendra | January 26, 2021 Singapore, 26 January 2021 – Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University (NTU) have developed a tool using CRISPRi technology that can help understand and prevent biofilm development, drug resistance, and other physiological behaviours of …
Hester’s revenues remain un-impacted in the current Bird Flu (Avian Influenza) disease outbreaks Kumar Jeetendra | January 22, 2021 As all are aware, there have been Bird Flu outbreaks across India. The spread of Bird Flu has been mainly through migratory wild birds. In the winter months, wild birds migrate to the tropical areas, India being in the tropics. These birds may have been infected with Bird Flu. They carry the disease along their …
SPT Labtech announces acquisition of Apricot Designs Kumar Jeetendra | January 21, 2021 Cambridge, UK – 21 January 2021 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of Apricot Designs Inc., headquartered in Covina, California. Apricot Designs has established a 30-year track record supporting increasingly complex and evolving laboratory research requirements with the …
New CRO from China joins Repositive Cancer Model network, increasing model database size by 87% Kumar Jeetendra | January 21, 2021 CAMBRIDGE, UK – (January 21, 2021) – Repositive has announced today that IDMO will be joining its global network of CRO partners. Based internationally in China, IDMO is a fast-growing CRO with over 6 years of experience in developing mouse PDX models for cancer research and personalised medicine. With this new partnership, Repositive is expanding …
The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis Kumar Jeetendra | January 19, 2021 Neuried, Germany – 19 January 2021 –The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. Most of the approximately 12,000 mutations in the genome of the SARS-CoV-2 virus that have been identified …
Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases Kumar Jeetendra | January 16, 2021 Dundee, UK, 14th January 2021 – Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York today announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. The collaboration will be supported by a Global Challenges Research Fund grant, awarded by …
Sartorius to acquire Novasep’s chromatography process equipment division Kumar Jeetendra | January 13, 2021 The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained. Novasep’s division expects to generate sales revenue of approximately 37 …
HiMedia Launches a ground-breaking 11 minute Automated Viral RNA Extraction Kumar Jeetendra | January 9, 2021 In a major breakthrough, HiGenoMB®, the Molecular Biology section of HiMedia Laboratories Pvt. Ltd. launches the quickest and the easiest 11 minute automated RNA extraction protocol. The Super 11 Pre-filled Plates for Insta NX® Mag96 (MB615MPF9611) enables processing of 96 samples in just eleven minutes! In challenging times like these, the pre-filled reagents in this …
Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London Kumar Jeetendra | January 5, 2021 Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection, …
Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel Kumar Jeetendra | December 21, 2020 Waltham, Mass – December 21, 2020 – Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution. Building on Cytel’s advanced software platform and leading biometrics services …
John Bell & Croyden celebrates key role of community pharmacists during covid-19 Kumar Jeetendra | December 16, 2020 London, UK – 16 December 2020 –John Bell & Croyden – holders of the Royal Warrant and pharmacists to Her Majesty the Queen – are celebrating the key role that community pharmacists have played during COVID-19. The renowned pharmacy emporium – who have kept their doors opened through two world wars and now a pandemic …
Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities Kumar Jeetendra | December 16, 2020 Nottingham and Alderley Park, UK – 16th December 2020 – Life Science Newswire – Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical contract research organization, is strengthening its high-throughput screening (HTS) and translational oncology service-offerings by investing £3 million in new instrumentation and equipment. Sygnature’s Translational Oncology department at Alderley Park is currently …
